
CDNA
Healthcare · Diagnostics & Research · $4.09B market cap
$77.88-1.93 (-2.4%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +42.1% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 29, 2026 | After the close | 0.07 | 0.70 | +900.0% |
| Jul 30, 2026 | After the close | 0.06 | 0.37 | +516.7% |
| Apr 28, 2026 | After the close | 0.13 | 0.34 | +161.5% |
| Feb 24, 2026 | Time not confirmed | -0.01 | 0.12 | +1300.0% |
| Nov 4, 2025 | After the close | 0.14 | 0.28 | +100.0% |
| Aug 6, 2025 | After the close | 0.12 | 0.10 | -16.7% |
| Apr 30, 2025 | After the close | 0.07 | 0.10 | +42.9% |
| Feb 26, 2025 | After the close | 0.15 | 0.18 | +22.0% |
| Nov 4, 2024 | After the close | 0.01 | 0.14 | +1300.0% |
| Jul 31, 2024 | After the close | -0.14 | 0.25 | +278.6% |
| May 9, 2024 | After the close | -0.21 | -0.03 | +85.7% |
| Feb 28, 2024 | After the close | -0.27 | -0.17 | +37.0% |
| Nov 8, 2023 | After the close | -0.40 | -0.18 |
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients;…
| +55.0% |
| Aug 8, 2023 | After the close | -0.31 | -0.18 | +41.9% |
| May 10, 2023 | After the close | -0.10 | -0.11 | -10.0% |
| Feb 27, 2023 | After the close | -0.09 | -0.07 | +22.2% |
| Nov 3, 2022 | After the close | -0.14 | -0.06 | +57.1% |
| Aug 4, 2022 | After the close | -0.11 | -0.13 | -18.2% |
| May 5, 2022 | After the close | -0.04 | -0.13 | -225.0% |
| Feb 24, 2022 | After the close | 0.03 | -0.03 | -200.0% |
| Oct 28, 2021 | After the close | 0.02 | 0.07 | +250.0% |
| Jul 29, 2021 | After the close | 0.06 | 0.11 | +83.3% |
| May 5, 2021 | After the close | 0.01 | 0.14 | +1300.0% |
| Feb 24, 2021 | After the close | 0.02 | 0.08 | +300.0% |
| Oct 29, 2020 | After the close | -0.06 | 0.10 | +266.7% |
| Aug 4, 2020 | After the close | -0.04 | 0.04 | +200.0% |
| Apr 30, 2020 | After the close | 0.03 | -0.14 | -566.7% |
| Feb 27, 2020 | After the close | 0.02 | 0.04 | +100.0% |
| Oct 31, 2019 | After the close | 0.01 | 0.02 | +100.0% |
| Aug 1, 2019 | After the close | -0.10 | -0.19 | -90.0% |
| May 8, 2019 | After the close | -0.04 | 0.05 | +225.0% |
| Mar 6, 2019 | After the close | -0.09 | 0.01 | +111.1% |
| Nov 8, 2018 | After the close | -0.03 | -0.01 | +66.7% |
| Aug 9, 2018 | After the close | -0.07 | -0.04 | +42.9% |
| May 10, 2018 | After the close | -0.13 | -0.14 | -7.7% |
| Mar 22, 2018 | After the close | -0.13 | -0.09 | +30.8% |